Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 17 medicines
FDA · 17 medicines
AIFA · 13 medicines
Anvisa · 12 medicines
SFDA · 12 medicines · Historical list
MS · 7 medicines · Historical list
PHARMAC · 5 medicines
HSA · 3 medicines
HALMED · 2 medicines
ALIMS · 2 medicines
EMA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
17 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sumatriptan | United States | 20MG/SPRAY, 5MG/SPRAY | spray | Marketed | Cipla |
| Sumatriptan Succinate | United States | 4MG BASE/0.5ML, 6MG BASE/0.5ML | injectable | Marketed | PH Health |
| Sumatriptan Succinate | United States | 100MG, 100MG BASE, 25MG … | tablet | Marketed | Watson Labs |
| Sumatriptan and Naproxen SodiumCombination | United States | 500MG; 85MG BASE | tablet | Marketed | Sun Pharm |
| Sumatriptan; Naproxen SodiumCombination | United States | 85MG; 500MG | tablet | Tentative approval | Par Pharm |
| Zembrace Symtouch | United States | 3MG BASE/0.5ML | solution | Marketed | Tonix Meds |
| Imitrex | United States | 100MG BASE, 25MG BASE, 50MG BASE | tablet | Marketed | Glaxosmithkline |
| Imitrex | United States | 10MG/SPRAY, 20MG/SPRAY, 5MG/SPRAY | spray | Marketed | Glaxosmithkline |
| Tosymra | United States | 10MG/SPRAY | spray | Marketed | Tonix Meds |
| Imitrex Statdose | United States | 4MG BASE/0.5ML, 6MG BASE/0.5ML | injectable | Marketed | Glaxosmithkline |
| Sumavel Dosepro | United States | 4MG BASE/0.5ML, 6MG BASE/0.5ML | injectable | Not marketed | Endo Operations |
| Onzetra Xsail | United States | 11MG BASE | powder | Marketed | Currax |
| SumansetronCombination | United States | Status unknown | |||
| Alsuma | United States | 6MG BASE/0.5ML | injectable | Not marketed | Meridian Medcl |
| Imitrex | United States | 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Glaxosmithkline |
| Zecuity | United States | 6.5MG BASE/4HR | system | Not marketed | Teva Branded Pharm |
| TreximetCombination | United States | 500MG; 85MG BASE, 60MG; 10MG BASE | tablet | Marketed | Currax |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
